A Discussion with Healthcare Private Equity Executives - The Impact of COVID-19 and How it is Influencing their Investing
Join the following private equity executives, and John Soden, Managing Director at Cain Brothers, a division of KeyBanc Capital Markets, as they discuss challenges of and investment strategies in the COVID-19 crisis:
- Ben Magnano, Managing Partner, Frazier Healthcare Partners
- Dan Agroskin, Managing Director & Mgnt Committee Member, JLL Partners
- Tony Davis, President & Managing Partner, Linden Capital Partners
Ben joined Frazier Healthcare Partners in 2006. He represents Frazier on the boards of Caravel Autism Health, Comprehensive Pharmacy Services, Matrix Medical Network, Northfield Medical, Parata and United Derm Partners. Ben has been responsible for Frazier’s successful investments in Ascension Orthopedics (acquired by Integra Lifesciences NASDAQ: IART), DSI Renal (merged with U.S. Renal Care and ultimately acquired by Bain Capital), Golden State Medical Supply (acquired by Court Square Capital Partners) and Laboratory Supply Company (acquired by McKesson NYSE: MCK). He also manages human capital recruitment for Frazier’s Growth Buyout practice.
Prior to Frazier, Ben was an Associate at Morgan Stanley Partners (MSP), focusing on growth equity investing in the healthcare sector. Before joining MSP, he was an analyst in the healthcare investment banking group of Morgan Stanley. Earlier, he spent time at Arthur Andersen.
Ben is also an advisor for American Corporate Partners, a nationwide mentoring program dedicated to helping veterans transition to the private sector.
Mr. Magnano received his M.B.A from the Tuck School of Business at Dartmouth and his B.B.A from the University of Notre Dame.
Dan Agroskin joined JLL Partners in 2005 and serves as one of its Managing Partners and a member of the Investment Committee. Prior to joining JLL, Mr. Agroskin worked at J.P. Morgan Partners and in the Mergers & Acquisitions Group at Merrill Lynch. Mr. Agroskin earned a B.A. with distinction from Stanford University and an M.B.A. from the Wharton School at the University of Pennsylvania.
Tony Davis is the President, a Managing Partner and Co-Founder of Linden Capital Partners. He has been involved in private equity and consulting since 1992. He currently serves on the boards of Advarra, ProPharma, Smile Doctors and Spear Education and is Chairman of the boards of Sage Dental and Virtus Pharmaceuticals. He previously served on the boards of directors for Behavioral Centers of America, Drayer Physical Therapy Institute, Focused Health Solutions, Ranir and Young Innovations. Additionally, Mr. Davis is a member of the Chicago Commonwealth Club, The Chicago Council on Global Affairs, The Commercial Club of Chicago and The Economic Club of Chicago. Tony is a Trustee of the Museum of Science and Industry and is a Director on the Northwestern Memorial Foundation Board of Directors and a member of the Northwestern Memorial Foundation Executive Committee. Tony was selected by the U.S. Department of Health and Human Services Deputy Secretary as a member of the Deputy Secretary’s Innovation and Investment Summit (DSIIS).
Mr. Davis holds a Bachelor of Arts with honors in Economics from Northwestern University and an MBA with honors from the University of Chicago Booth School of Business, where he was a Rosett Scholar and serves on the Polsky Center Private Equity Council and as a guest lecturer on private equity.